Endpoints NewsRoche plans to pit next-gen hemophilia A antibody against Hemlibra in Phase 33 days agoBy Lei Lei WuMore
GuruFocusEarly data suggest Roche's NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A | RHHBY Stock News3 days agoMore
World Pharmaceutical FrontiersRoche unveils promising Phase 1/2 results for NXT007 in haemophilia A2 days agoMore
PharmExecRoche’s Next-Gen Bispecific Antibody Shows Early Promise in Hemophilia A2 days agoBy Don TracyMore
YahooEarly data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A3 days agoMore
Full CoverageFull Coverage